Aspira Pathlab & Diagnostics Ltd Quarterly Results
Q1 FY25-26 Results Summary
Revenue
The revenue stands at ₹5.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.17 per cent from ₹5.78 crore. This corresponds to a year-on-year *(YoY) growth of 13.15 per cent.
Operating Profit
Operating Profit stands at ₹0.68 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.09 per cent from ₹0.92 crore. This corresponds to a year-on-year *(YoY) growth of 151.85 per cent.
PBDT
PBDT stands at ₹0.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 24.76 per cent from ₹1.05 crore. This corresponds to a year-on-year *(YoY) growth of 83.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 38.24 per cent from ₹0.68 crore. This corresponds to a year-on-year *(YoY) growth of 740.00 per cent.
Net Profit
Net Profit stands at ₹0.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 38.24 per cent from ₹0.68 crore. This represents a 740.00 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Aspira Pathlab & Diagnostics Ltd Earnings
- YOY
- QOQ
Aspira Pathlab & Diagnostics Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Aspira Pathlab & Diagnostics Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Aspira Pathlab & Diagnostics Ltd Financial Reports
Aspira Pathlab & Diagnostics Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Aspira Pathlab | -7.43% | -7.20% | 0.60% | -10.15% | -1.81% | -6.02% |
| M E T S | 1.69% | 0.71% | 4.19% | 17.63% | 1.29% | -3.47% |
| Choksi Laborator | 0.40% | 1.61% | 2.64% | -13.59% | -28.75% | -15.57% |
| Sunil Healthcare | -2.14% | 3.01% | 6.84% | -8.06% | -15.01% | -3.37% |
| Shree Pacetronix | 3.62% | 4.26% | 27.75% | 2.27% | -48.22% | 113.55% |
| Bandaram Pharma | -6.32% | 0.99% | -1.39% | -7.68% | -3.38% | -32.95% |
| N G Industries | -0.70% | -8.63% | -0.47% | -11.12% | -5.18% | -19.56% |
Company Info
Company Information
Chairman & Independent Directo : Haseeb A Drabu
Managing Director & CEO : Pankaj Jashwant Shah
Executive Director : Nikunj Mange
Independent Non Exe. Director : Manas Mengar
Company Sec. & Compli. Officer : Krupali Shah
Addtnl Independent Director : Kiran Raghavendra Awasthi